How Climbing Senecio May Help Fight Liver Cancer
Author Information
Author(s): Jiang Jiayi, Wu Haitao, Jiang Xikun, Ou Qing, Gan Zhanpeng, Han Fangfang, Cai Yongming
Primary Institution: Guangdong Pharmaceutical University
Hypothesis
This study aims to identify the molecular targets and pathways through which Climbing senecio regulates hepatocellular carcinoma (HCC).
Conclusion
Climbing senecio may target multiple pathways and genes in regulating HCC, suggesting potential drug effects through a multi-target mechanism.
Supporting Evidence
- Eleven components of Climbing senecio were identified, along with 520 relevant targets and 300 differentially expressed genes.
- Key genes such as AKR1B1, CA2, FOS, CXCL2, SRC, ABCC1, and PLIN1 were found to intersect between HCC-related genes and Climbing senecio targets.
- Significant factors in HCC onset and progression include TGFβ, IL-1, VEGF, and CXCL.
Takeaway
Researchers found that a plant called Climbing senecio might help treat liver cancer by affecting many different genes and pathways.
Methodology
The study used network pharmacology, gene expression data analysis, and molecular docking to identify targets and pathways related to Climbing senecio's effects on HCC.
Potential Biases
Potential errors in target identification due to reliance on database accuracy.
Limitations
The research relies on network database analysis and bioinformatics, necessitating further validation through clinical studies.
Participant Demographics
The study included 56 liver disease-related samples, with 10 from normal livers and 46 from various stages of HCC.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website